# Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

> **NCT00317473** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 135 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **BIOLOGICAL:** FMP1/AS02A Malaria vaccine
- **BIOLOGICAL:** Imovax Rabies vaccine

## Key facts

- **NCT ID:** NCT00317473
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-07
- **Final completion:** 2005-07
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2017-10-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317473, "Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00317473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*